IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ORECCHIA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 31.190
AS - Asia 20.138
NA - Nord America 19.522
SA - Sud America 2.122
AF - Africa 507
OC - Oceania 127
Continente sconosciuto - Info sul continente non disponibili 32
Totale 73.638
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.829
DE - Germania 12.014
CN - Cina 5.781
IT - Italia 5.490
SG - Singapore 5.480
GB - Regno Unito 5.101
HK - Hong Kong 1.921
RU - Federazione Russa 1.838
BR - Brasile 1.522
SE - Svezia 1.494
BD - Bangladesh 1.431
VN - Vietnam 1.388
FR - Francia 1.123
IN - India 946
NL - Olanda 749
TR - Turchia 709
IE - Irlanda 675
UA - Ucraina 640
KR - Corea 607
JP - Giappone 492
FI - Finlandia 487
CA - Canada 391
ID - Indonesia 370
ES - Italia 338
EU - Europa 261
PL - Polonia 241
CO - Colombia 183
MX - Messico 162
BE - Belgio 159
AR - Argentina 155
DK - Danimarca 154
PH - Filippine 153
CI - Costa d'Avorio 139
TH - Thailandia 138
AT - Austria 124
AU - Australia 106
EG - Egitto 106
TW - Taiwan 105
GR - Grecia 99
PT - Portogallo 86
IQ - Iraq 82
EC - Ecuador 79
PK - Pakistan 79
CH - Svizzera 77
ZA - Sudafrica 73
RO - Romania 66
SA - Arabia Saudita 66
IR - Iran 54
CL - Cile 52
VE - Venezuela 41
MY - Malesia 38
MA - Marocco 37
NO - Norvegia 36
CZ - Repubblica Ceca 35
PE - Perù 35
AE - Emirati Arabi Uniti 34
UZ - Uzbekistan 32
JO - Giordania 30
KE - Kenya 29
CR - Costa Rica 26
NP - Nepal 25
IL - Israele 24
NG - Nigeria 24
PY - Paraguay 23
HU - Ungheria 22
DO - Repubblica Dominicana 20
LB - Libano 20
UY - Uruguay 20
BG - Bulgaria 19
GT - Guatemala 19
GE - Georgia 17
NZ - Nuova Zelanda 17
AL - Albania 16
DZ - Algeria 15
HN - Honduras 15
LT - Lituania 15
AZ - Azerbaigian 14
KZ - Kazakistan 14
SK - Slovacchia (Repubblica Slovacca) 14
LU - Lussemburgo 13
OM - Oman 13
SN - Senegal 12
KW - Kuwait 11
PR - Porto Rico 11
BO - Bolivia 10
JM - Giamaica 10
MD - Moldavia 10
TN - Tunisia 10
SV - El Salvador 9
LK - Sri Lanka 8
PA - Panama 8
SC - Seychelles 8
CY - Cipro 7
EE - Estonia 7
ET - Etiopia 7
KH - Cambogia 7
MT - Malta 7
SI - Slovenia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AM - Armenia 6
Totale 73.728
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 10.644
Southend 4.463
Singapore 3.190
Ashburn 2.025
Hong Kong 1.720
Chandler 1.381
San Jose 1.274
Milan 1.240
Beijing 1.037
Seattle 949
Dallas 824
Princeton 797
Council Bluffs 669
Dublin 664
Wilmington 651
Los Angeles 538
Houston 523
Jacksonville 482
Santa Clara 465
Fairfield 461
New York 452
Bengaluru 412
Ho Chi Minh City 409
Lauterbourg 370
Nanjing 362
Mountain View 325
Rome 320
Hanoi 317
Guangzhou 316
Redmond 310
Buffalo 299
Moscow 278
Dearborn 277
Des Moines 268
Shanghai 252
Woodbridge 251
Boardman 240
Tokyo 239
Ann Arbor 217
Hefei 202
Toronto 195
Sakarya 189
Cambridge 182
Columbus 178
Helsinki 168
São Paulo 167
Istanbul 160
Hangzhou 159
Jinan 159
Jakarta 158
Munich 153
Bogotá 147
The Dalles 146
Cangzhou 141
Phoenix 141
Abidjan 138
Tianjin 136
Andover 133
Amsterdam 132
Shenyang 132
Volpiano 132
Serra 126
Berlin 116
Nanchang 106
Warsaw 105
Seoul 103
Chicago 94
Naples 91
Bangkok 90
Nuremberg 87
Changsha 85
Athens 84
Grafing 84
Brussels 81
Redwood City 80
Shenzhen 79
Turin 72
Somerville 69
Da Nang 68
London 68
Mumbai 66
Barcelona 65
Hebei 65
Bologna 63
Eitensheim 62
San Diego 61
Washington 60
Sanok 57
Vienna 55
Cernusco 54
Madrid 51
Haiphong 50
Rio de Janeiro 50
Atlanta 49
Jiaxing 49
Montreal 49
Taipei 49
Florence 47
Fuzhou 47
Paris 47
Totale 46.143
Salva come PNG Salva come JPEG
Nome #
A randomized trial of robotic mastectomy versus open surgery in women with breast cancer or BRCA mutation 4.369
Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective 1.581
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management 725
De-escalating and escalating treatments for early-stage breast cancer : the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 536
Association of quantitative mri-based radiomic features with prognostic factors and recurrence rate in oropharyngeal squamous cell carcinoma 439
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 413
Application of failure mode and effects analysis to treatment planning in scanned proton beam radiotherapy 400
Linee guida carcinoma della prostata : AIRO, 2016 394
Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment 388
Adjuvant radiotherapy treatment for soft tissue sarcoma of extremities and trunk. A retrospective mono-institutional analysis 350
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) 346
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial 346
Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy 324
STRA-MI-VT (STereotactic RadioAblation by Multimodal Imaging for Ventricular Tachycardia) : rationale and design of an Italian experimental prospective study 323
No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy 313
Tailoring therapies-improving the management of early breast cancer : St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 310
Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer 305
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 302
Correlation between administered treatment and patient's living will 301
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218) 299
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) 296
[11C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy 293
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 293
Intra-tumoral Salmonella typhimurium induces a systemic anti-tumor immune response that is directed by low-dose radiation to treat distal disease 290
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300) 290
Hodgkin's lymphoma emerging radiation treatment techniques : trade-offs between late radio-induced toxicities and secondary malignant neoplasms 289
High-performance prediction models for prostate cancer radiomics 288
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach 284
MR imaging for selection of patients for partial breast irradiation : a systematic review and meta-analysis 283
Head and neck cancer radiotherapy amid COVID‐19 pandemic : Report from Milan, Italy 279
A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin : interim analysis 276
Management of cardiac disease in cancer patients throughout oncological treatment : ESMO consensus recommendations 276
Initial clinical experience with scanned proton beams at the Italian National Center for Hadrontherapy (CNAO) 270
Standard operating procedures for biobank in oncology 269
A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer : accurate review of management and perspectives 265
Low Dose Rate Brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy : Practice and outcome analysis in a series of 2237 patients from 11 Institutions 264
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy 263
HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breast 263
Late toxicity of image-guided hypofractionated radiotherapy for prostate : non-randomized comparison with conventional fractionation 261
High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study 261
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series 259
Intra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clips 259
Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA-MI-VT phase Ib/II study 256
Dose prescription in carbon ion radiotherapy : a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy 255
Quality of life in patients with chordomas/chondrosarcomas during treatment with proton beam therapy 255
Benefits of six degrees of freedom for optically driven patient set-up correction in SBRT 253
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors 253
Comparing TomoHelical and TomoDirect in postmastectomy hypofractionated radiotherapy after immediate breast reconstruction 252
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 252
Impact of a dedicated radiologist as a member of the head and neck tumour board : a single-institution experience 251
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion : ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218 250
Tossicità con radioterapia e brachiterapia 249
3D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART) combined with external beam radiation therapy 249
Exploring mirna signature and other potential biomarkers for oligometastatic prostate cancer characterization: The biological challenge behind clinical practice : a narrative review 249
Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional study 241
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 240
Oral Surgery and Osteoradionecrosis in Patients Undergoing Head and Neck Radiation Therapy: An Update of the Current Literature 239
Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma 239
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 239
Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy 238
Radiation survey around a Liac mobile electron linear accelerator for intraoperative radiation therapy 237
Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer : the PANDORA-01 trial 236
Proton beam radiotherapy : report of the first patient treated at the Centro Nazionale di Adroterapia Oncologica (CNAO) [National Center of Oncologic Hadron Therapy] 236
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer 236
Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience 232
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: A single centre analysis of toxicity and clinical outcome 231
Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial 228
A study for the application of prospective approaches for safety assessment in new radiotherapy techniques 227
Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy 227
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer 226
Deep inspiration breath-hold technique guided by an opto- electronic system for extracranial stereotactic treatments 226
Machine Learning for Head and Neck Cancer: A Safe Bet?—A Clinically Oriented Systematic Review for the Radiation Oncologist 226
New frontiers in proton therapy : applications in breast cancer 223
Mixed-beam approach for high-risk prostate cancer : Carbon-ion boost followed by photon intensity-modulated radiotherapy. Dosimetric and geometric evaluations (AIRC IG-14300) 223
Accelerated partial breast irradiation with intraoperative electrons : using GEC-ESTRO recommendations as guidance for patient selection 222
Virtual and Augmented Reality as a Novel Opportunity to Unleash the Power of Radiotherapy in the Digital Era: A Scoping Review 221
Assessment of pulmonary fibrosis after radiotherapy (RT) in breast conserving surgery: comparison between conventional external beam RT (EBRT) and intraoperative RT with electrons (ELIOT) 221
High-sensitivity analysis of clonal hematopoiesis reveals increased clonal complexity of potential-driver mutations in severe COVID-19 patients 220
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial 220
Prognostic significance of neutrophil‐to‐lymphocyte ratio in HPV status era for oropharyngeal cancer 219
Hypofractionated proton therapy in breast cancer: where are we? A critical review of the literature 219
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation 218
Primary and recurrent retroperitoneal sarcoma : factors affecting survival and long-term outcome 217
Radiotherapy in prostate cancer patients with pelvic lymphocele after surgery: clinical and dosimetric data of 30 patients 217
Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases 217
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial 216
COVID-19 and radiotherapy: impact on work and personal life of Lombardy residents during first lockdown, survey endorsed by AIRO Young 216
Influence of different urinary bladder filling levels and controlling regions of interest selection on deformable image registration algorithms 215
Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients 214
Reply to 'the St Gallen international expert consensus on the primary therapy of early breast cancer 2017: Te point of view of an international panel of experts in radiation oncology' by Kirova et al 213
Proton beam radiotherapy : report of the first ten patients treated at the Ccentro Nazionale di Adroterapia Oncologica (CNAO) for skull base and spine tumours 211
High precision radiotherapy including intensitymodulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: A retrospective monoinstitutional study 211
Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly/frail patients treated with 3D and IMRT technique 211
Pulsed dose-rate perioperative interstitial brachytherapy for soft tissue sarcomas of the extremities and skeletal muscles of the trunk 210
Diarrhoea in irradiated patients : a prospective multicentre observational study 210
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence : A Multi-institutional Analysis 209
Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters : Is it Oncologically Safe? A Matched-Cohort Analysis 209
Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience 207
Adjuvant high-dose-rate interstitial brachytherapy for malignant peripheral nerve sheath tumor of the foot: A case report 206
Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma 205
Totale 32.083
Salva come PNG Salva come JPEG
Categoria #
all - tutte 184.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.345
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021277 0 0 0 0 0 0 0 0 0 0 0 277
2021/20223.780 249 145 129 148 266 247 367 227 361 380 229 1.032
2022/20236.091 700 516 497 655 576 1.097 239 465 592 188 340 226
2023/202411.290 198 382 337 276 850 483 1.659 1.503 729 1.475 1.689 1.709
2024/202513.212 1.643 1.690 1.322 1.263 824 465 341 1.157 654 901 1.037 1.915
2025/202621.840 1.952 1.328 2.197 1.620 1.933 1.374 2.772 1.146 2.134 1.511 2.566 1.307
Totale 76.629